Skip to content
value.today

MedRhythms, Inc.

🇺🇸 Portland, Maine, USATechnologyFounded 2015
Total raised
$60 M
8 rounds on record
Latest round
$1 M
Jul 2026
First round on record
Jun 2018
Today
Private
No later event on record

Funding rounds

8 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of MedRhythms, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2026$1 MNo. 8Under $2 million

MedRhythms, Inc.: Raise no. 8, Jul 2026

Investors in this round

1 investor had bought by the notice of Aug 7, 2026: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Harris · Executive Officer, Director
  • Owen McCarthy · Executive Officer, Director
  • Christopher Harris · Director
  • Isaac Cheng · Director
  • Jean Hoffman · Director
  • Musan Duric · Director
  • William McKee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 7, 2026. Read the notice at the SEC.

debt, optionsSEC
Feb 2026$3 MNo. 7$2 to $10 million

MedRhythms, Inc.: Raise no. 7, Feb 2026

Investors in this round

31 investors had bought by the notice of Mar 2, 2026: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $6 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Lawrence Jasinski · Executive Officer, Director
  • Owen McCarthy · Executive Officer, Director
  • Christopher J. Harris · Director
  • Isaac J. Cheng · Director
  • Jean Hoffman · Director
  • Peter J. Werth · Director
  • William J. McKee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amounts include conversion of certain outstanding convertible securities. A portion of the Total Remaining to be Sold will be issued and sold upon the Company achieving certain contingencies at a milestone closing.”

Signed by Lawrence Jasinski, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 2, 2026. Read the notice at the SEC.

equitySEC
Mar 2025$3 MNo. 6$2 to $10 million

MedRhythms, Inc.: Raise no. 6, Mar 2025

Investors in this round

3 investors had bought by the notice of Apr 3, 2025: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $8 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Harris · Executive Officer, Director
  • Owen McCarthy · Executive Officer, Director
  • Christopher J. Harris · Director
  • Isaac J. Cheng · Director
  • Jean Hoffman · Director
  • Peter J. Werth · Director
  • William J. McKee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 3, 2025. Read the notice at the SEC.

debt, optionsSEC
Nov 2023$20 MNo. 5$10 to $50 million

MedRhythms, Inc.: Raise no. 5, Nov 2023

Investors in this round

20 investors had bought by the notice of Jan 9, 2024: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $26 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Harris · Executive Officer, Director
  • Owen McCarthy · Executive Officer, Director
  • Christopher J. Harris · Director
  • Isaac J. Cheng · Director
  • Jean Hoffman · Director
  • Peter J. Werth · Director
  • William J. McKee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • LIFESCI CAPITAL, LLC (CRD 168404) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “Includes conversion of outstanding Notes into shares of Preferred Stock.”

Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 9, 2024. Read the notice at the SEC.

equitySEC
Feb 2023$6 MNo. 4$2 to $10 million

MedRhythms, Inc.: Raise no. 4, Feb 2023

Investors in this round

6 investors had bought by the notice of Feb 22, 2023: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Harris · Executive Officer, Director
  • Owen McCarthy · Executive Officer, Director
  • Christopher J. Harris · Director
  • Jean Hoffman · Director
  • Peter J. Werth · Director
  • Ray Pawlicki · Director
  • Stephen J. Bruso · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 22, 2023. Read the notice at the SEC.

debt, optionsSEC
Jul 2021$21 MNo. 3$10 to $50 million

MedRhythms, Inc.: Raise no. 3, Jul 2021

Investors in this round

23 investors had bought by the notice of Jul 28, 2021: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $27 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$891,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Harris · Executive Officer, Director
  • Owen McCarthy · Executive Officer, Director
  • Christopher Harris · Director · Became a director following financing closing.
  • Jean Hoffman · Director
  • Peter Werth · Director
  • Raymond Pawlicki · Director
  • Stephen Bruso · Director · Became a director following financing closing.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • MTS Securities, LLC (CRD 104059) · New York, New YorkSold in CA, MA, NH, NY

Remarks in the notice

  • On the amounts: “Includes conversion of outstanding Notes into shares of Preferred Stock.”

Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 28, 2021. Read the notice at the SEC.

equitySEC
Aug 2019$1 MNo. 2Under $2 million

MedRhythms, Inc.: Raise no. 2, Aug 2019

Investors in this round

7 investors had bought by the notice of Aug 22, 2019: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$180,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Harris · Executive Officer, Director
  • Owen McCarthy · Executive Officer, Director
  • Jean Hoffman · Director
  • Peter Werth · Director
  • Raymond Pawlicki · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The Issuer estimates that it will pay approximately $180,000 per year to the Related Persons as compensation.”

Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 22, 2019. Read the notice at the SEC.

equitySEC
Jun 2018$5 MNo. 1$2 to $10 million

MedRhythms, Inc.: Raise no. 1, Jun 2018

Investors in this round

14 investors had bought by the notice of Jul 11, 2018: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$80,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Harris · Executive Officer, Director
  • Owen McCarthy · Executive Officer, Director
  • Jean Hoffman · Director
  • Raymond Pawlicki · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amounts include conversion of outstanding convertible securities of Issuer.”
  • On the use of proceeds: “The Issuer estimates that it will pay approximately $80,000 per year to the Related Persons as compensation.”

Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 11, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • MedRhythms, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2026).

    SEC Form D · Aug 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Aug 2026

That is all the official record says: MedRhythms, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of MedRhythms, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 8 rounds above had up to 31 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by MedRhythms, Inc.
NameRoleNamed in
Brian HarrisExecutive officerAug 2026
Owen McCarthyExecutive officerAug 2026
Lawrence JasinskiExecutive officerMar 2026
Brian HarrisDirectorAug 2026
Christopher HarrisDirectorAug 2026
Isaac ChengDirectorAug 2026
Jean HoffmanDirectorAug 2026
Musan DuricDirectorAug 2026
Owen McCarthyDirectorAug 2026
William McKeeDirectorAug 2026
Christopher J. HarrisDirectorMar 2026
Isaac J. ChengDirectorMar 2026
Lawrence JasinskiDirectorMar 2026
Peter J. WerthDirectorMar 2026
William J. McKeeDirectorMar 2026
Bill McKeeDirectorDec 2023
Peter WerthDirectorDec 2023
Raymond PawlickiPrior Director of the Company.Dec 2023
Stephen BrusoDirectorDec 2023
Ray PawlickiDirectorFeb 2023
Stephen J. BrusoDirectorFeb 2023